Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Singapore

Singapore Articles

Industry

BMI View: German drugmaker Bayer is unlikely to repeat its so-far impressive performance in Asia Pacific in the remainder of 2011, primarily due to the region's stagnating attractiveness... 2011-07-07


Industry

BMI View: Attention deficit hyperactivity disorder (ADHD) represents a small but growing opportunity for pharmaceutical companies operating in South East Asia. The prevalence of the... 2011-05-04


Industry

BMI View: High standards of medical care and knowledge will work towards boosting growth in Singapore's medical tourism sector. A recent government survey revealed that 76% of the patients... 2011-04-18


More ARTICLES

Industry

BMI Core View: Non-healthcare companies, particularly technology firms, will increasingly enter the medical services sector. Companies see healthcare as a sustainable and expanding... 2011-04-14


Industry

BMI View: Singapore's healthcare sector is small, but will post steady growth over the next decade. The key drivers of this expansion are a growing economy, an ageing population, more... 2011-02-15


Industry

BMI View: Singapore has a low risk pharmaceutical market. Despite having an economy that is highly dependent on exports (demand for which is inherently volatile), the country is committed... 2011-02-10


Industry

BMI View: Asia Pacific's attractiveness to multinational drugmakers is faltering. BMI's Pharmaceuticals & Healthcare Business Environment Ratings (BERs), which assess countries... 2011-01-14


Industry

BMI Core View: Non-healthcare companies, particularly technology firms, will increasingly enter the medical services sector. Companies see healthcare as a sustainable and expanding... 2010-11-25